Offering healthcare facilities with the option to either use a flexible daily-leased rubidium program or build a full time PET program will ultimately increase access for suspected CAD patients to state of the art imaging with cardiac PET.
News | PET Imaging
Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
The conference focuses on the enduring value of ACC Accreditation and NCDR services for achieving quality care
News | Cardiovascular Education
ACC Quality Summit Explores Practical Strategies to Reboot and Rebrand Healthcare Quality

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
According to new research published in Mayo Clinic Proceedings, calculating the patient's mean arterial pressure (AugMAP) is a simple and effective way to identify those patients who may benefit from more aggressive treatment strategies.
News | Structural Heart
Mayo Clinic Researchers Develop Calculation to Identify High-risk Moderate Aortic Stenosis Patients

October 5, 2023 — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis ...

Home October 05, 2023
Home
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure
News | FDA
Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

October 4, 2023 — Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in ...

Home October 04, 2023
Home
2023 MedAxiom Cardiovascular Provider Compensation and Production Survey Report aggregates data on private vs. integrated practice, APP to physician ratios, patient volumes and subspeciality considerations
News | Cardiovascular Business
Cardiology Compensation and Production Remain Relatively Stable Year-over-year

October 4, 2023 — MedAxiom, a premier source for cardiovascular organizational performance solutions, has released its ...

Home October 04, 2023
Home
Nearly 900 Butterfly devices have been distributed throughout Ukraine via global health partnerships, with Razom alone contributing more than 400 units
News | Point-of-Care Ultrasound (POCUS)
Butterfly Network and Razom Expand Global Health Partnership To Bring Additional 200 Butterfly iQ+ Ultrasound Systems to Ukraine

October 4, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable ...

Home October 04, 2023
Home
DAIC JACC LVad sci statement
News | Heart Failure
JACC Issues Scientific Statement Exploring Impact of dLVAD on Quality of Life for HF Patients

October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue ...

Home October 04, 2023
Home
DAIC ACC Logo
News | Artificial Intelligence
American College of Cardiology and Serv Medical Announce Collaboration on Digital Health Care Innovation

October 4, 2023 — The American College of Cardiology (ACC) recently announced that it has started a strategic innovation ...

Home October 04, 2023
Home
EnCompass plans to immediately initiate clinical site start-up activities in the US
News | FDA
EnCompass receives FDA conditional IDE approval to commence a US pilot study of its F2 cerebral embolic protection (CEP) system in patients undergoing transcatheter aortic valve replacement (TAVR)

October 3, 2023 — EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients ...

Home October 03, 2023
Home
The LUX-Dx II+ ICM System product design
News | Implantable Cardiac Monitor (ICM)
Boston Scientific launches LUX-Dx II+ Insertable Cardiac Monitor System

October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation ...

Home October 03, 2023
Home
Theodore Teruya, MD, and Sally Schonefeld, MD, Join Huntington Health, an affiliate of Cedars-Sinai, expanding vascular surgery expertise in San Gabriel Valley
News | Cardiovascular Business
Smidt Heart Institute Welcomes 2 Pasadena-Based Vascular Surgeons

October 3, 2023 — Vascular surgeons Theodore Teruya, MD, and Sally Schonefeld, MD, have joined the Division of Vascular ...

Home October 03, 2023
Home
A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease.
News | Pediatric Cardiology
Researchers Uncover Why a Gene Mutant Causes Young Children to Have Strokes

October 3, 2023 — A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD ...

Home October 03, 2023
Home
The qXR-CTR is a deep-learning-based computer vision algorithm designed for use by physicians
News | Artificial Intelligence
FDA Clears Qure.ai's qXR-CTR Chest X-ray Solution as a Potential Indicator for Identifying Heart Failure Risk

September 29, 2023 — Qure.ai, a leading global innovator in radiology AI solutions, has announced FDA clearance for ...

Home September 29, 2023
Home
Beilinson Hospital in Israel used Nanox.AI’s HealthCCSng solution to conduct study on routine chest CT scans to assess impact of AI-based coronary artery calcium (CAC) measurements
News | Computed Tomography (CT)
Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
Application based on clinically meaningful results from the Phase 3 STELLAR trial
News | Cardiovascular Clinical Studies
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)

September 28, 2023 — Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a ...

Home September 28, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now